[1] Yao RQ, Ren C, Zheng LY, et al. Advances in immune monitoring approaches for sepsis-induced immunosuppression. Front Immunol, 2022; 13, 891024. doi:  10.3389/fimmu.2022.891024
[2] Su JQ, Zhou F, Wu S, et al. Research progress on natural small-molecule compounds for the prevention and treatment of sepsis. Int J Mol Sci, 2023; 24, 12732. doi:  10.3390/ijms241612732
[3] Wu MQ, Lai HB, Peng W, et al. Monotropein: a comprehensive review of biosynthesis, physicochemical properties, pharmacokinetics, and pharmacology. Front Pharmacol, 2023; 14, 1109940. doi:  10.3389/fphar.2023.1109940
[4] Chen YE, Lu YY, Pei CY, et al. Monotropein alleviates secondary liver injury in chronic colitis by regulating TLR4/NF-κB signaling and NLRP3 inflammasome. Eur J Pharmacol, 2020; 883, 173358. doi:  10.1016/j.ejphar.2020.173358
[5] Zhang YP, Chen YE, Li BX, et al. The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis. Biomed Pharmacother, 2020; 129, 110408. doi:  10.1016/j.biopha.2020.110408
[6] Seemann S, Zohles F, Lupp A. Comprehensive comparison of three different animal models for systemic inflammation. J Biomed Sci, 2017; 24, 60. doi:  10.1186/s12929-017-0370-8
[7] Marey AM, Dkhil MA, Abdel-Moneim AE, et al. Unraveling the immune response of the spleen in sepsis using green-synthesized silver nanoparticles from pomegranate peel extracts. Microsc Res Tech, 2024; 87, 2034−42. doi:  10.1002/jemt.24575
[8] Busch K, Kny M, Huang N, et al. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy. J Cachexia Sarcopenia Muscle, 2021; 12, 1653−68. doi:  10.1002/jcsm.12763
[9] Luo J, Wang J, Zhang J, et al. Nrf2 deficiency exacerbated CLP-induced pulmonary injury and inflammation through autophagy- and NF-κB/PPARγ-mediated macrophage polarization. Cells, 2022; 11, 3927. doi:  10.3390/cells11233927
[10] Gao F, Qian MJ, Liu GY, et al. USP10 alleviates sepsis-induced acute kidney injury by regulating sirt6-mediated Nrf2/ARE signaling pathway. J Inflamm (Lond), 2021; 18, 25. doi:  10.1186/s12950-021-00291-7